Course of Fecal Calprotectin after mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Diseases

Background: Two years into the pandemic, vaccination remains the most effective option to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Preliminary studies suggest vaccination efficacy in patients with inflammatory bowel diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Pokryszka, Jagoda, Wagner, Angelika, Wiedermann, Ursula, Tobudic, Selma, Herkner, Harald, Winkler, Stefan, Brehovsky, Sonja, Reinisch, Walter, Novacek, Gottfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146449/
https://www.ncbi.nlm.nih.gov/pubmed/35632515
http://dx.doi.org/10.3390/vaccines10050759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146449/
https://www.ncbi.nlm.nih.gov/pubmed/35632515
http://dx.doi.org/10.3390/vaccines10050759

Ejemplares similares